2.23.2015

Fingerpaint Makes Additions in Account Service, Medical Strategy


SARATOGA SPRINGS, NY – Fingerpaint (http://fingerpaintmarketing.com) just got smarter. Award-winning account director Kori-Ann Taylor joins the account service team, while Rajneesh P. Uzgare brings a PhD in immunology to the agency’s medical strategy team.

Taylor is a communications industry veteran with a portfolio of experience that includes senior communications positions within state government serving Governor George Pataki, Senator Thomas Morahan and the Lower Manhattan Development Corporation. She brings a wealth of pharmaceutical agency experience to Fingerpaint as well, having been recognized several times over for her leadership in working with such clients as BMS/AstraZeneca on global diabetes marketing initiatives and Amylin, Eli Lilly, Gilead and Roche Diagnostics on U.S. marketing initiatives.

(Taylor)


Taylor earned her bachelor’s degree at The College of Saint Rose and her master’s from State University of New York at Albany.

Uzgare has more than a decade of experience in biotech, specialty pharmaceuticals and academia, having penned a successful cancer research grant application as a fellow at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He specializes in pharmaceutical research, pharmaceutical program planning and development, and strategic execution. He brings his philosophy of client-agency scientific partnering to Fingerpaint.

(Uzgare)


Uzgare earned his undergraduate and master’s degrees in microbiology at Bombay University in Mumbai, and his PhD in immunology at Baylor College of Medicine in Houston, Texas.

“Kori-Ann is a communications pro, and she understands how to tactfully and effectively deliver the appropriate message, whether from a top government official or a client,” said Ed Mitzen, Fingerpaint founder. “And it’s hard to find people as intelligent, innovative and driven as Raj. We’re thrilled we did.”

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

Links to this post:

Create a Link

<< Home